carbidopa has been researched along with Neuroendocrine Tumors in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Addeo, P; Averous, G; Bachellier, P; Imperiale, A; Namer, IJ | 1 |
Santhanam, P; Taïeb, D | 1 |
Garske, U; Orlefors, H; Sundin, A | 1 |
2 review(s) available for carbidopa and Neuroendocrine Tumors
Article | Year |
---|---|
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Nuclear imaging of neuroendocrine tumours.
Topics: 3-Iodobenzylguanidine; 5-Hydroxytryptophan; Carbidopa; Glucose-6-Phosphate; Humans; Levodopa; Neuroendocrine Tumors; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin | 2007 |
1 other study(ies) available for carbidopa and Neuroendocrine Tumors
Article | Year |
---|---|
Solid pseudopapillary pancreatic tumor mimicking a neuroendocrine neoplasm on ¹⁸F-FDOPA PET/CT.
Topics: Adult; Carbidopa; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agents; Fluorine Radioisotopes; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |